BioCentury
ARTICLE | Clinical News

Nulojix belatacept regulatory update

February 18, 2013 8:00 AM UTC

Bristol-Myers and Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband) said they reached an agreement on the price for Nulojix belatacept to prevent organ rejection in adult kid...